Clinical Trials
2 trialsNCT00882973 2017-05-05
Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic Cancer
Samyang Biopharmaceuticals Corporation
Phase 1 Completed
NCT00877253 2012-06-12
Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer
Samyang Biopharmaceuticals Corporation
Phase 1 Completed